ArticleBritish journal of cancer2012

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.

S Bellone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.